Incidence and outcomes of acute lung injury.

By G. Rubenfeld, E. Caldwell, E. Peabody, J. Weaver, Diane P. Martin, M. Neff, E. Stern, L. Hudson. New England Journal of Medicine, 2005

3,731 citations recorded by the source corpus.

Subfields: Epidemiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/d78580766f383bcd821e279b7df1a07a5dbd3807

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Yaron Ogen
2. Michael A. Matthay

In Pulmonary and Respiratory Medicine

1. Michael A. Matthay
2. R. Zemans
3. Arthur S Slutsky
4. N. Gupta
5. V. Serikov

Citations in the corpus

• Acute Respiratory Distress Syndrome: Advances in Diagnosis and Treatment (2018, background): “the United States, resulting in nearly 75 000 deaths, more than breast cancer or HIV infection.(2) Globally, ARDS affects approxi-”
• The Acute Respiratory Distress Syndrome: Pathogenesis and Treatment (2011, background): “In 2005, the incidence of acute lung injury (ALI) and ARDS in adults was estimated to be approximately 200,000 patients annually in the United States, with a mortality of approximately 40% (4).”
• Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung (2009, neutral): “0001 Endotoxin 54,199 [30,995, 77,812] MSC 31,770 [16,272, 66,330] MSC CM 33,092 [2,636, 51,672] IL-10 (pg/ml) Control 0 [0, 0] 0.”
• Into the Eye of the Cytokine Storm (2012, background): “Acute lung injury (ALI) is a common consequence of a cytokine storm in the lung alveolar environment and systemic circulation and is most commonly associated with suspected or proven infections in the lungs or other organs (121).”
• Pulmonary Innate Immune Response Determines the Outcome of Inflammation During Pneumonia and Sepsis-Associated Acute Lung Injury (2020, background): “Earlier studies have shown that the sepsis is responsible for more than 210,000 cases of ALI/ARDS in the US alone/annually, causing over 74,500 deaths (184, 185).”
• Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial. (2008, methodology): “Days of neuromuscular blocker use, median (IQR) 2 (1-5) 3 (1-6)”
• Critical care and the global burden of critical illness in adults (2010, background): “30 Parallel increases can be expected for sepsis 24 demand might be especially acute in the USA, in which use of ICU by hospital patients who die is very high (47% vs 10% in England), especially for elderly people.”
• Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1 (2007, background): “Despite improvements in supportive care, recent data indicate that the mortality of acute respiratory failure from ALI is still high at 40% (1, 2).”
• Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. (2012, background): “Introduction Almost 200,000 persons in the US develop acute lung injury (ALI) every year (1) from a variety of causes, including sepsis, bacterial pneumonia, aspiration of gastric contents, and epidemic viruses, such as H1N1 and SARS.”
• Assessing nitrogen dioxide (NO2) levels as a contributing factor to coronavirus (COVID-19) fatality (2020, background): “, 2000), poor lung function in adults or lung injury (Bowatte et al., 2017; Rubenfeld et al., 2005) and diabetes (Saeha et al.”
• Has mortality from acute respiratory distress syndrome decreased over time?: A systematic review. (2009, background): “Indeed, recent data from multicenter observational studies suggest that ARDS mortality in unselected patients may range from 39% (28) to as high as 50 to 60% (26, 29, 30).”